Sept 23 (Reuters) - Vaxil Bio Ltd VXL.V :
* BGN TECHNOLOGIES - LICENSES POLYMER FOR TARGETED CANCER THERAPY TO VAXIL BIO
* BGN TECHNOLOGIES LICENSES POLYMER FOR TARGETED CANCER THERAPY TO VAXIL BIO
* BGN TECHNOLOGIES - ENTERED AN EXCLUSIVE WORLDWIDE LICENSE AGREEMENT WITH VAXIL BIO FOR DEVELOPMENT AND COMMERCIALIZATION OF TARGETED CANCER THERAPY